Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
about
Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?Small intestinal bacterial overgrowth syndromeIntestinal microbiota in functional bowel disorders: a Rome foundation reportIrritable bowel syndrome: new insights into symptom mechanisms and advances in treatmentRifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled TrialsThe malabsorption of commonly occurring mono and disaccharides: levels of investigation and differential diagnosesAbdominal bloating: pathophysiology and treatmentUpper gastrointestinal microbiota and digestive diseasesGut microbiota as potential orchestrators of irritable bowel syndromeHydrogen breath tests in gastrointestinal diseasesColonic hypersensitivity is a major determinant of the efficacy of bloating treatment in constipation-predominant irritable bowel syndrome.Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome.Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months.A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome.Diagnosis and management of small intestinal bacterial overgrowth.Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance.Breath tests and irritable bowel syndrome.Rational Use of Antibiotics in the Treatment of Functional Bowel DisordersSmall Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic DichotomyLower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.The Relationship between Small-Intestinal Bacterial Overgrowth and Intestinal Permeability in Patients with Irritable Bowel Syndrome.Low-dose nocturnal tegaserod or erythromycin delays symptom recurrence after treatment of irritable bowel syndrome based on presumed bacterial overgrowth.Irritable bowel syndrome: a clinical reviewBacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptorsThe prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.The treatment of irritable bowel syndromeDo probiotics improve symptoms in patients with irritable bowel syndrome?Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype.A role for the gut microbiota in IBS.Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.Comparison of the antibacterial activity of essential oils and extracts of medicinal and culinary herbs to investigate potential new treatments for irritable bowel syndrome.Gut microbial diversity in rat model induced by rhubarb.Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics.Rifaximin treatment for symptoms of irritable bowel syndrome.Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac diseaseAntibiotics for irritable bowel syndrome: rationale and current evidence.Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress.Small bowel bacterial overgrowth in patients with irritable bowel syndrome: the first study in iranIrritable bowel syndrome: diagnostic approaches in clinical practice.
P2860
Q21261900-EC2845CE-BBC2-4A54-8C59-09685DE4AA88Q24262889-963E8799-95B9-4CAF-8DA6-5021A69D5870Q24631357-C62F4080-5326-4606-B3F1-859296F7A38DQ26751193-018752AC-62FB-4151-8422-7D9927892F2AQ26772962-903B9ABA-9A1C-4793-9B22-187CED31462BQ26822538-B13F8335-EF4D-4ACE-8383-B4884D9B37EDQ26851622-F434FB07-08F9-4049-8958-B30E95FED5AFQ27002380-EC218AAB-DB19-450A-B16F-0E776138430AQ28085584-9E7148AA-C74F-4E0C-BC47-DEE56823B39DQ28249439-CC8CFC0D-8CEB-460B-B5FB-3FEDB7135AF2Q33448962-F48B731F-4576-4A2B-B3A6-AB5F9E5A9A06Q33449179-9BB2A81E-9D4E-4BC9-8873-8B4E38441F4CQ33456102-13805B5C-36C7-4755-935A-6790A7F503CCQ33457676-D5376394-D69C-4B31-9B7F-1522733C1582Q33457767-D6272904-96D0-4D29-A0AE-F53DA4433435Q33459081-3802C0A1-D37A-43B2-A84F-C7D1C36D9539Q33462070-B199CBFC-6E08-4593-9831-FB2DDCC9959CQ33468935-5442C01A-10CA-4B3C-9B61-81E43A60D606Q33469991-E5F8D976-8606-44C2-B9CC-A33AC5B7BE34Q33780866-A0884201-AD52-4E05-B49D-2444DEDC3323Q33781658-40BBFAB8-92AD-4293-BC3F-F18195F0B3EDQ33916182-1B8ABA8F-B764-4E74-A04B-86659F55E737Q34168517-1589F648-4A14-49DB-A218-DF0547E3F0F9Q34170707-C0692886-16AA-48DA-9BBB-5CE53DD3636AQ34231605-1EA666F1-D68D-477C-A4C6-5AFB6BE5269EQ34248518-2E7733DA-E3AB-4410-A6A0-8B323E9753EAQ34409009-5B4B68D5-8F19-42A5-9852-F54BEFB0F216Q34409031-9B8F2D93-3335-45FB-8829-F2C4E1572641Q34410012-C466CF7C-6D5E-4E82-9EFD-9C7D7E0D3E59Q34416297-90DC0310-95F2-4C9A-9F4F-EBB87DEE394FQ34449503-4A1542CF-DC07-4DA8-99D5-FD4ACFA35378Q34454007-D95053A2-0E7B-4D3D-9257-560B66D47BD5Q34572668-9B33CB78-FD82-4E1F-891F-33C60DA7D19EQ34585072-8FF9F9D6-AF26-47A2-ABE8-BC2D83457372Q34588803-4961CAD3-E082-470A-80F5-731A4AFD2932Q34595882-1EF24BCF-7230-41D0-8C39-A63B5181040EQ34642080-14EE480E-739F-43EE-977A-3325FBFCF9B2Q34778810-B2BA3388-0D75-42A6-8598-A10D629B914CQ34950787-B9DD9E8B-94CB-4687-AD41-556214BF63F1Q35026362-3AF097EF-4303-4036-A0F9-83628A7F64EA
P2860
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
@ast
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
@en
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
@nl
type
label
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
@ast
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
@en
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
@nl
prefLabel
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
@ast
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
@en
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
@nl
P2093
P2860
P3181
P356
P1433
P1476
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
@en
P2093
Einar S Björnsson
Hasse Abrahamsson
Iris Posserud
Per-Ove Stotzer
P2860
P3181
P356
10.1136/GUT.2006.108712
P407
P577
2007-06-01T00:00:00Z